A new approach to the design and evaluation of T cell vaccines for cancer and infectious diseases

Lahoud, Mireille (Primary Chief Investigator (PCI))
Miles, John (Chief Investigator (CI))
Radford, Kristen (Chief Investigator (CI))
Rodwell, Robyn (Chief Investigator (CI))

Biochemistry & Molecular Biology

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 31/12/17

Funding

National Health and Medical Research Council (NHMRC) (Australia): A$105,000.00

3 Article

Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A
Lahoud, M. H. & Radford, K. J., 2022, In: Human Vaccines and Immunotherapeutics. 18, 1, 5 p., 1873056.
Research output: Contribution to journal › Article › Other › peer-review

Open Access

6 Citations (Scopus)
Human CLEC9A antibodies deliver Wilms' tumor 1 (WT1) antigen to CD141⁺ dendritic cells to activate naïve and memory WT1-specific CD8⁺ T cells
Pearson, F. E., Tullett, K. M., Leal-Rojas, I. M., Haigh, O. L., Masterman, K. A., Walpole, C., Bridgeman, J. S., McLaren, J. E., Ladell, K., Miners, K., Llewellyn-Lacey, S., Price, D. A., Tunger, A., Schmitz, M., Miles, J. J., Lahoud, M. H. & Radford, K. J., 2020, In: Clinical & Translational Immunology. 9, 6, 15 p., e1141.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

29 Citations (Scopus)
Targeting CLEC9A delivers antigen to human CD141⁺ DC for CD4⁺ and CD8⁺ T cell recognition
Tullett, K. M., Leal Rojas, I. M., Minoda, Y., Tan, P. S., Zhang, J. G., Smith, C., Khanna, R., Shortman, K., Caminschi, I., Lahoud, M. H. & Radford, K. J., 19 May 2016, In: JCI Insight. 1, 7, 12 p., e87102.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

68 Citations (Scopus)